IQVIA Holdings Inc
NYSE:IQV
IQVIA Holdings Inc
Cash from Operating Activities
IQVIA Holdings Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
19%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Operating Activities
$8.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Danaher Corp
NYSE:DHR
|
Cash from Operating Activities
$7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Cash from Operating Activities
$756.6m
|
CAGR 3-Years
14%
|
CAGR 5-Years
21%
|
CAGR 10-Years
14%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Operating Activities
$965.9m
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Operating Activities
$2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
See Also
What is IQVIA Holdings Inc's Cash from Operating Activities?
Cash from Operating Activities
2.1B
USD
Based on the financial report for Dec 31, 2023, IQVIA Holdings Inc's Cash from Operating Activities amounts to 2.1B USD.
What is IQVIA Holdings Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
19%
Over the last year, the Cash from Operating Activities growth was -5%. The average annual Cash from Operating Activities growth rates for IQVIA Holdings Inc have been 3% over the past three years , 11% over the past five years , and 19% over the past ten years .